Evidence map›Paper›PMID 37295825›Full record

ArticleBMJ open2023

Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada: a cross-sectional study.

Shaza Almweisheer, Charles N Bernstein, Lesley A Graff, Scott B Patten, James Bolton, John D Fisk, Carol A Hitchon, James J Marriott, Ruth Ann Marrie, CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease

Abstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shaza AlmweisheerInternal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Charles N BernsteinDepartment of Gastroenterology, University of Manitoba, Winnipeg, Manitoba, Canada.
Lesley A GraffClinical Health Psychology, University of Manitoba, Winnipeg, Manitoba, Canada.
Scott B PattenCommunity Health Sciences & Psychiatry, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
James BoltonDepartment of Psychiatry, University of Manitoba, Winnipeg, Manitoba, Canada.
John D FiskNova Scotia Health Authority, Halifax, Nova Scotia, Canada.
Carol A HitchonInternal Medicine, University of Manitoba College of Medicine, Winnipeg, Manitoba, Canada.ORCID 0000-0001-5547-3268
James J MarriottInternal Medicine, University of Manitoba College of Medicine, Winnipeg, Manitoba, Canada.
Ruth Ann MarrieInternal Medicine, University of Manitoba College of Medicine, Winnipeg, Manitoba, Canada rmarrie@hsc.mb.ca.ORCID 0000-0002-1855-5595
CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease

Funding

CIHR THC-135234
6 · The paper itself

Abstract

objectivesAmong people with immune-mediated inflammatory disease (IMID), including multiple sclerosis (MS), inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) most research has focused on mental illness rather than on mental health. We assessed dimensions of mental health among persons with IMID and compared them across IMID. We also evaluated demographic and clinical characteristics associated with flourishing mental health.

designParticipants: Adults with an IMID (MS, 239; IBD, 225; RA 134; total 598) who were participating in a cohort study.

settingTertiary care centre in Manitoba, Canada. PRIMARY OUTCOME MEASURE: Participants completed the Mental Health Continuum Short-Form (MHC-SF), which measures emotional, psychological and social well-being, and identifies flourishing mental health. This outcome was added midway through the study on the advice of the patient advisory group. Depression, anxiety, pain, fatigue and physical function were also assessed.

resultsTotal MHC-SF and subscale scores were similar across IMID groups. Nearly 60% of participants were considered to have flourishing mental health, with similar proportions across disease types (MS 56.5%; IBD 58.7%; RA 59%, p=0.95). Older age was associated with a 2% increased odds of flourishing mental health per year of age (OR 1.02; 95% CI: 1.01 to 1.04). Clinically meaningful elevations in anxiety (OR 0.25; 95% CI: 0.12 to 0.51) and depressive symptoms (OR 0.074; 95% CI: 0.009 to 0.61) were associated with lower odds. Higher levels of pain, anxiety and depressive symptoms were associated with lower total Mental Health Continuum scores at the 50th quantile.

conclusionsOver half of people with MS, IBD and RA reported flourishing mental health, with levels similar across the disease groups. Interventions targeting symptoms of depression and anxiety, and upper limb impairments, as well as resilience training may help a higher proportion of the IMID population achieve flourishing mental health.

Indexed as

Arthritis, RheumatoidInflammatory Bowel DiseasesMultiple SclerosisAdultCanadaCohort StudiesCross-Sectional StudiesHumansManitobaMental HealthPaindepression & mood disordersinflammatory bowel diseasemental healthmultiple sclerosisrheumatology

Identifiers

PMID37295825
PMCPMC10277148

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.